Correlation of MYC Gene and Protein Status With Breast Cancer Subtypes and Outcome of Patients Treated With Anthracycline-Based Adjuvant Chemotherapy. Pooled Analysis of 2 Hellenic Cooperative Group Phase III Trials-Reference-Cited by-同舟云学术

Correlation of MYC Gene and Protein Status With Breast Cancer Subtypes and Outcome of Patients Treated With Anthracycline-Based Adjuvant Chemotherapy. Pooled Analysis of 2 Hellenic Cooperative Group Phase III Trials

Published:2018-02 Issue:1 Volume:18 Page:53-62.e3
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Batistatou Anna,Kotoula Vassiliki,Bobos Mattheos,Kouvatseas George,Zagouri Flora,Tsolaki Eleftheria,Gogas Helen,Koutras Angelos,Pentheroudakis George,Timotheadou Eleni^ORCID,Pervana Stavroula,Goussia Anna,Petraki Kalliopi,Sotiropoulou Maria,Koletsa Triantafyllia,Razis Evangelia^ORCID,Kosmidis Paris,Aravantinos Gerasimos,Papadimitriou Christos,Pectasides Dimitrios,Fountzilas George

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference35 articles.

1. Molecular portraits of human breast tumours;Perou;Nature,2000

2. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;Sorlie;Proc Natl Acad Sci U S A,2001

3. Breast cancer classification and prognosis based on gene expression profiles from a population-based study;Sotiriou;Proc Natl Acad Sci U S A,2003

4. Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort;Celis;Mol Oncol,2009

5. Triple-negative breast cancer;Foulkes;N Engl J Med,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential predictive value of circulating tumor DNA (ctDNA) mutations for the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer;Frontiers in Genetics;2023-03-16

2. Serum LAPTM4B as a Potential Diagnostic and Prognostic Biomarker for Breast Cancer;BioMed Research International;2022-11-30

3. MYC as a therapeutic target for the treatment of triple-negative breast cancer: preclinical investigations with the novel MYC inhibitor, MYCi975;Breast Cancer Research and Treatment;2022-07-30

4. Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC;BMC Cancer;2020-05-18

5. MYC gene associated polymorphisms and Wilms tumor risk in Chinese children: a four-center case-control study;Annals of Translational Medicine;2019-09